Alzheimer's Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018–2025 - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
October 18, 2018 Newswires
Share
Share
Post
Email

Alzheimer’s Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018–2025

ReleaseWire

Las Vegas, NV -- (ReleaseWire) -- 10/17/2018 -- The report "Alzheimer's Drugs Market By Drug Class (Combined Drug, Memantine, Cholinergic and Other Drug Class) – Global Forecast to 2025", issued by Crystal Market Research, the market has come across substantial development in the recent years and is projected to grow significantly over the forecast period.

Alzheimer's Drugs Market By Drug Class and Distribution Channel - Global Industry Analysis And Forecast To 2025: Industry Outlook
Alzheimer's is a kind of dementia which causes issues with thinking, behavior and memory of the person suffering. Indications for the most part grow gradually and deteriorate after some time, getting to be sufficiently serious to hinder the day to day tasks. The Alzheimer's ailment is given the name after Dr. Alois Alzheimer. Dr. Alzheimer saw changes in the tissue of brain of a lady who died due to an uncommon psychological illness. The side effects she showed included language problems, memory loss, and an unpredictable behavior. The use of drugs for treating Alzheimer's is growing due to increasing number of cases related to the disease, rising awareness amongst the population across the globe for treatment procedure of the disease, etc. Therefore, the Alzheimer's Drugs Market is anticipated to expand and has tremendous scope during the forecast period. The global Alzheimer's Drugs Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Global Alzheimer's Drugs Market: Competitive Analysis
The increasing investment in research and development by the players is triggering competition in the global Alzheimer's Drugs market.

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
Merz Holding GmbH & Co KG

H Lundbeck A/S

Novartis AG

Ono Pharmaceutical

Allergan plc

Johnson & Johnson

Daiichi Sankyo Company Limited

Eisai Co Ltd.

The strategic mergers and acquisitions among the players of the global Alzheimer's Drugs market are leading to the expansion of this market.

To get overview of exclusive sample report at: https://www.crystalmarketresearch.com/report-sample/HC101402

Global Alzheimer's Drugs Market: Segmentation Overview
On the basis of Drug Class, the market is further divided into Combined Drug, Memantine, Cholinergic and Other Drug Class. The section Memantine is leading the market due to factors like; long term expiry of patents related to main products, less numbers of medicines to for Alzheimer's disorders treatment, etc.

On the basis of Distribution Channel, the market is further divided into Online Sales, Retail Pharmacy and Hospital Pharmacy. The Hospital Pharmacy section is dominating the market owing to rising demand from the people for disease treatment, rise in the number of people admitted to hospital for treatment, etc.

Global Alzheimer's Drugs Market: Regional Insights
The North American region is leading the global Alzheimer's Drugs Market owing to factors like; huge number of the population suffering from this disease, rising awareness amongst the local population about the disease treatment options available, etc.

By Region: North America: (U.S., Canada & Mexico), Europe: (Germany, UK, France, Russia, Italy & Rest of Europe), Asia-Pacific: (China, Japan, South Korea, India, Southeast Asia & Rest of Asia-Pacific), South America: (Brazil, Argentina, Columbia, South Africa & Rest of South America) and Middle East and Africa: (Saudi Arabia, UAE, Egypt, Nigeria, South Africa & Rest of MEA)

Inquire about This Report at: https://www.crystalmarketresearch.com/send-an-enquiry/HC101402

Major ToC of Global Alzheimer's Drugs Market:
Chapter 1. Introduction
1.1. Report Description
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
Chapter 4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2014-2025)
4.1.2. Canada Market Status and Outlook (2014-2025)
4.1.3. Mexico Market Status and Outlook (2014-2025)
...
Chapter 5. Alzheimer's Drugs Market, By Drug Class
5.1. Introduction
5.2. Global Alzheimer's Drugs Revenue and Market Share by Drug Class (2014-2018)
5.2.1. Global Alzheimer's Drugs Revenue and Revenue Share by Drug Class (2014-2018)
5.3. Combined Drug
5.3.1. Global Combined Drug Revenue and Growth Rate (2014-2018)
5.4. Memantine
5.4.1. Global Memantine Revenue and Growth Rate (2014-2018)
5.5. Cholinergic
5.5.1. Global Cholinergic Revenue and Growth Rate (2014-2018)
5.6. Other Drug Class
5.6.1. Global Other Drug Class Revenue and Growth Rate (2014-2018)

Browse Report Description with Complete ToC at: https://www.crystalmarketresearch.com/report/alzheimers-drugs-market

Chapter 6. Alzheimer's Drugs Market, By Distribution Channel

Chapter 7. Alzheimer's Drugs Market, By Region

Chapter 8. Company Profiles

Chapter 9. Global Alzheimer's Drugs Market Competition, by Manufacturer

Chapter 10. Alzheimer's Drugs Market Forecast (2018-2025)

…Read Full Table of Contents

Reasons to Buy the Report:
This report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the rapid microbiology testing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

(Early customers will receive 10% customization in this report.)

Avail Quality Discount at: https://www.crystalmarketresearch.com/check-discount/HC101402

About Crystal Market Research:
Crystal Market Research (CMR) is a main industry insight arrangement that gives all statistical surveying reports from top distributers, a U.S. based market research and business Intelligence Company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contacts Us:
Judy | 304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
E-mail: [email protected] | Tel: +1-888-213-4282
Web: www.crystalmarketresearch.com

For more information on this press release visit: http://www.releasewire.com/press-releases/alzheimers-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2018-2025-1067393.htm

Media Relations Contact

Crystal Market Research
Crystal Market Research
Telephone: 1-347-352-0883
Email: Click to Email Crystal Market Research
Web: https://www.crystalmarketresearch.com/customization/HC101402

Older

Connecticut Insurance Commissioner Backs $69 Billion CVS Purchase Of Aetna

Newer

SailPoint Celebrates Identity Champions at Navigate ’18 Europe

Advisor News

  • Different generations are hopeful about their future, despite varied goals
  • Geopolitical instability and risk raise fears of Black Swan scenarios
  • Structured Note Investors Recover $1.28M FINRA Award Against Fidelity
  • Market reports turn economic trends into a strategic edge for advisors
  • SEC in ‘active and detailed’ settlement talks with accused scammer Tai Lopez
More Advisor News

Annuity News

  • Life Insurance and Annuity Providers Score High Marks from Financial Pros, but Lag on User Friendliness, JD Power Finds
  • An Application for the Trademark “TACTICAL WEIGHTING” Has Been Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
  • Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
  • Rethinking whether annuities are too late for older retirees
  • Advising clients wanting to retire early: how annuities can bridge the gap
More Annuity News

Health/Employee Benefits News

  • What Idaho Senate just did about mini-hospital firm accused of ‘excessive’ rates
  • Inmates exiting Green Hill, Echo Glen now eligible for expanded health care coverage
  • AM Best to Host Briefing on Negative Pressures on U.S Health Insurance Segment and Whether an Inflection Point has Arrived
  • Long-Term Care Insurance: A lifeline or a financial nightmare for seniors?
  • New CEO at major health insurer with 3K CT employees. ‘Excited to build on our strong foundation’
More Health/Employee Benefits News

Life Insurance News

  • AM Best Affirms Credit Ratings of Cincinnati Financial Corporation and Subsidiaries
  • NAIFA and Brokers Ireland launch global partnership
  • Life Insurance and Annuity Providers Score High Marks from Financial Pros, but Lag on User Friendliness, JD Power Finds
  • Reimagining life insurance to close the coverage gap
  • Busch, Pacific Life settle dispute over $8.5M investmentFormer NASCAR champion Kyle Busch settles $8.5M lawsuit against life insurance companyTwo-time NASCAR champion Kyle Busch and a life insurance company have settled an $8.5 million lawsuit in which the driver said he was misled into purchasing policies marketed as safe retirement plans
More Life Insurance News

- Presented By -

Top Read Stories

More Top Read Stories >

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Elevate Your Practice with Pacific Life
Taking your business to the next level is easier when you have experienced support.

Your Cap. Your Term. Locked.
Oceanview CapLock™. One locked cap. No annual re-declarations. Clear expectations from day one.

Ready to make your client presentations more engaging?
EnsightTM marketing stories, available with select Allianz Life Insurance Company of North America FIAs.

Press Releases

  • RFP #T25521
  • ICMG Announces 2026 Don Kampe Lifetime Achievement Award Recipient
  • RFP #T22521
  • Hexure Launches First Fully Digital NIGO Resubmission Workflow to Accelerate Time to Issue
  • RFP #T25221
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet